Michael A. Narachi
2014
In 2014, Michael A. Narachi earned a total compensation of $4.5M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $432,422 |
|---|---|
| Option Awards | $3,417,406 |
| Salary | $640,625 |
| Other | $8,816 |
| Total | $4,499,269 |
Narachi received $3.4M in option awards, accounting for 76% of the total pay in 2014.
Narachi also received $432.4K in non-equity incentive plan, $640.6K in salary and $8.8K in other compensation.
Rankings
In 2014, Michael A. Narachi's compensation ranked 1,822nd out of 13,032 executives tracked by ExecPay. In other words, Narachi earned more than 86.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,822 out of 13,032 | 86th |
Division Manufacturing | 646 out of 4,966 | 87th |
Major group Chemicals And Allied Products | 203 out of 1,686 | 88th |
Industry group Drugs | 157 out of 1,365 | 89th |
Industry Pharmaceutical Preparations | 132 out of 1,043 | 87th |
Source: SEC filing on May 27, 2016.
Narachi's colleagues
We found four more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2014.
2014
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2014
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer outgoing
2014
Heather Turner
Orexigen Therapeutics
General Counsel
2014
Preston Klassen
Orexigen Therapeutics